Haloperidol Decanoate

Haloperidol Decanoate Brand names, Haloperidol Decanoate Analogs

Haloperidol Decanoate Brand Names Mixture

No information avaliable

Haloperidol Decanoate Chemical_Formula

C₂₁H₂₃ClFNO₂

Haloperidol Decanoate RX_link

http://www.rxlist.com/cgi/generic/haloper.htm

Haloperidol Decanoate fda sheet

Haloperidol_Decanoate FDA

Haloperidol Decanoate msds (material safety sheet)

Haloperidol_Decanoate MSDS

Haloperidol Decanoate Synthesis Reference

P. A. J. Janssen, Belg. pat. 577,977 (1959), C.A. 54, 4630c (1960); idem, Brit. pat. 895,309 corresp to U.S. pat. 3,438,991 (1962, 1969 to Janssen).

Haloperidol Decanoate Molecular Weight

375.864 g/mol

Haloperidol Decanoate Melting Point

151.5 ^oC

Haloperidol Decanoate H₂O Solubility

14 mg/L

Haloperidol Decanoate State

Solid

Haloperidol Decanoate LogP

4.362

Haloperidol Decanoate Dosage Forms

Injection; Oral solution; Tablet

Haloperidol Decanoate Indication

For the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy also used in Tourette's syndrome and Severe hyperactivity.

Haloperidol Decanoate Pharmacology

Haloperidol is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Haloperidol has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Haloperidol has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Haloperidol Decanoate Absorption

Oral-60%

Haloperidol Decanoate side effects and Toxicity

LD₅₀=165 mg/kg (rats, oral)

Haloperidol Decanoate Patient Information

PRD00538_PI.txt

Haloperidol Decanoate Organisms Affected

Humans and other mammals